Research Categories
- Anesthesia
- Arthroscopy
- Biologics/Biomaterials
- Cancer Devices
- Cardiovascular
- Cosmetic Devices
- Dental
- Diabetes
- Diagnostics
- Dialysis
- Drug Delivery
- Ear, Nose, Throat
- Endoscopy
- Gastrointestinal (GI)
- General Surgery
- Gynecology Devices
- Healthcare IT
- Hearing Devices
- Imaging
- Immunology
- Infusion Therapy
- Laparoscopy
- Minimally Invasive Surgery
- Neurology Devices
- Oncology
- Operating Room Equipment
- Ophthalmics Devices
- Orthopedics
- Patient Monitoring
- Peripheral Vascular
- Respiratory Devices
- Robotics & Navigation
- Sleep Apnea & Diagnostics
- Spine
- Stents
- Tissue Repair
- Urology
- Vascular Access
- Video Hi-Tech
- Women's Health
- Wound Care
Spine Biomaterials
Showing 1–12 of 13 results
Orthopedic Biomaterials Market Size, Share & Trends Analysis | United States | 2024-2030 | MedSuite | Includes: Bone Graft Substitutes, Orthopedic Growth Factors, Cellular Allografts, and 3 more
The full report suite on the U.S. market for orthopedic biomaterials includes bone graft substitutes, which are represented by allografts, demineralized bone matrices (DBMs), xenografts and synthetic bone graft markets. The report also includes orthopedic growth factors; cellular allografts; orthopedic cell therapy, represented by bone marrow aspirate concentrate and platelet-rich plasma; hyaluronic acid (HA) viscosupplementation in single-, two-, three- and five-injection cycles; and, finally, orthopedic cartilage repair. Cartilage repair is represented by the osteochondral allograft, meniscal allograft, autologous chondrocyte implantation, particulated juvenile allograft and microfracture adjunct segments.
more...Orthopedic Growth Factor Market Size, Share, and COVID-19 Impact Analysis | Global | 2023-2029 | MedCore
Growth factors are a group of small, soluble proteins that bind onto cell surface receptors, triggering a series of signals that regulate the body’s ability to grow, renew and heal. Due to the regenerative properties of growth factors, they have been exploited for bone healing in orthopedic applications.
more...Orthobiologics Market Analysis, Size, Trends | China | 2020-2026 | MedSuite
In 2020, the Chinese orthobiologics market size was valued at $460.7 million, with over 424,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 6% to reach $690.8 million in 2026. Throughout this medical market research, we analyzed 28 orthobiologics companies across China […]
more...Orthobiologics Market Analysis, Size, Trends | Japan | 2020-2026 | MedSuite
In 2020, the Japanese orthobiologics market size was valued at $426.9 million, with over 221,000 bone grafting procedures performed every year. The market size is expected to fluctuate over the forecast period with a -0.4% compound annual growth rate (CAGR). Throughout this medical market research, we analyzed 16 orthobiologics companies across Japan and used our […]
more...Orthobiologics Market Analysis, Size, Trends | India | 2020-2026 | MedSuite
In 2020, the Indian orthobiologics market size was valued at $76.2 million, with over 520,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 12.4% to reach $172.3 million in 2026. Throughout this medical market research, we analyzed 23 orthobiologics companies across India […]
more...Orthobiologics Market Analysis, Size, Trends | South Korea | 2020-2026 | MedSuite
In 2020, the South Korean orthobiologics market size was valued at $141.6 million, with over 200,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 3.6% to reach $181.5 million in 2026. Throughout this medical market research, we analyzed 16 orthobiologics companies across […]
more...Orthobiologics Market Analysis, Size, Trends | Australia | 2020-2026 | Medsuite
In 2020, the Australian orthobiologics market size was valued at $63.8 million, with over 29,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 4.9% to reach $89.4 million in 2026. Throughout this medical market research, we analyzed 48 orthobiologics companies across Australia […]
more...Bone Graft Substitutes Market Size, Share, and COVID-19 Impact Analysis | Global | 2023-2029 | MedCore | Includes: Allograft BGS, Synthetic BGS, and 1 more
The full report suite on the global market for bone graft substitutes (BGS) includes allograft BGS, demineralized bone matrix allograft BGS and synthetic BGS. The market is further analyzed by unit type. Specifically, they are divided by nine types of indication: cervical, thoracolumbar spine, non-union trauma, fresh facture trauma, hip bone, knee bone, foot bone, craniomaxillofacial and oncology.
more...